10.6084/m9.figshare.5938018.v1
V. Gnanapragasam
V.
Gnanapragasam
O. Bratt
O.
Bratt
K. Muir
K.
Muir
L. Lee
L.
Lee
H. Huang
H.
Huang
P. Stattin
P.
Stattin
A. Lophatananon
A.
Lophatananon
Additional file 7: of The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study
Springer Nature
2018
Prostate cancer
Prognostic prediction
Cancer-specific mortality
Cambridge Prognostic Groups
Non-metastatic disease
Stratification
All-cause mortality
Competing risks
Improved treatment section
Treatment selection
2018-02-28 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_7_of_The_Cambridge_Prognostic_Groups_for_improved_prediction_of_disease_mortality_at_diagnosis_in_primary_non-metastatic_prostate_cancer_a_validation_study/5938018
Table S7. Distribution of cases and deaths from prostate cancer and hazard ratios for each Cambridge Prognostic Group (CPG) in the PCBaSe radical radiotherapy cohort (n = 11,872). (DOCX 15 kb)